| Antiparasitic activity of risedronate in a murine model of acute Chagas’ disease LR Garzoni, MC Waghabi, MM Baptista, SL De Castro, ... International journal of antimicrobial agents 23 (3), 286-290, 2004 | 127 | 2004 |
| Implication of transforming growth factor–β1 in Chagas disease myocardiopathy TC Araújo-Jorge, MC Waghabi, AM Hasslocher-Moreno, SS Xavier, ... The Journal of Infectious Diseases 186 (12), 1823-1828, 2002 | 99 | 2002 |
| Pivotal role for TGF-β in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy TC Araújo-Jorge, MC Waghabi, CS Maria de Nazaré, M Keramidas, ... Cytokine & growth factor reviews 19 (5-6), 405-413, 2008 | 85 | 2008 |
| Pharmacological inhibition of transforming growth factor β signaling decreases infection and prevents heart damage in acute chagas' Disease MC Waghabi, EM de Souza, GM de Oliveira, M Keramidas, JJ Feige, ... Antimicrobial agents and chemotherapy 53 (11), 4694-4701, 2009 | 78 | 2009 |
| Activation of transforming growth factor β by Trypanosoma cruzi MC Waghabi, M Keramidas, JJ Feige, TC Araujo‐Jorge, S Bailly Cellular Microbiology 7 (4), 511-517, 2005 | 70 | 2005 |
| Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease FL de Oliveira, TC Araujo-Jorge, EM de Souza, GM de Oliveira, ... PLoS neglected tropical diseases 6 (6), e1696, 2012 | 69 | 2012 |
| TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease RR Ferreira, R da Silva Abreu, G Vilar-Pereira, W Degrave, ... PLoS neglected tropical diseases 13 (7), e0007602, 2019 | 65 | 2019 |
| SB-431542, a Transforming Growth Factor β Inhibitor, Impairs Trypanosoma cruzi Infection in Cardiomyocytes and Parasite Cycle Completion MC Waghabi, M Keramidas, CM Calvet, M Meuser, MNC Soeiro, ... Antimicrobial agents and chemotherapy 51 (8), 2905-2910, 2007 | 64 | 2007 |
| Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease RCG Fares, JAS Gomes, LR Garzoni, MC Waghabi, RM Saraiva, ... Infection and immunity 81 (10), 3600-3608, 2013 | 63 | 2013 |
| Increased Trypanosoma cruzi Invasion and Heart Fibrosis Associated with High Transforming Growth Factor β Levels in Mice Deficient in α2-Macroglobulin MC Waghabi, C Coutinho, MNC Soeiro, MCS Pereira, JJ Feige, ... Infection and immunity 70 (9), 5115-5123, 2002 | 63 | 2002 |
| The TGF‐β Pathway as an Emerging Target for Chagas Disease Therapy TC Araújo‐Jorge, MC Waghabi, S Bailly, JJ Feige Clinical Pharmacology & Therapeutics 92 (5), 613-621, 2012 | 60 | 2012 |
| Uptake of host cell transforming growth factor-β by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion MC Waghabi, M Keramidas, S Bailly, W Degrave, L Mendonça-Lima, ... The American journal of pathology 167 (4), 993-1003, 2005 | 58 | 2005 |
| Gap junction reduction in cardiomyocytes following transforming growth factor-β treatment and Trypanosoma cruzi infection MC Waghabi, R Coutinho-Silva, JJ Feige, ML Higuchi, D Becker, ... Memorias do Instituto Oswaldo Cruz 104, 1083-1090, 2009 | 48 | 2009 |
| Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion PM Ferrão, CM d'Avila-Levy, TC Araujo-Jorge, WM Degrave, ... PLoS One 10 (5), e0124832, 2015 | 44 | 2015 |
| Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease RR Ferreira, EM de Souza, FL de Oliveira, PM Ferrão, LHF Gomes, ... Immunobiology 221 (5), 587-594, 2016 | 34 | 2016 |
| Predictive value of transforming growth factor-β1in Chagas disease: towards a biomarker surrogate of clinical outcome RM Saraiva, MC Waghabi, MF Vilela, FS Madeira, GMS da Silva, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 107 (8 …, 2013 | 27 | 2013 |
| Scrutinizing the biomarkers for the neglected Chagas disease: how remarkable! RT Pinho, MC Waghabi, F Cardillo, J Mengel, PRZ Antas Frontiers in immunology 7, 216069, 2016 | 24 | 2016 |
| Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial MC Chambela, MFF Mediano, FM Carneiro, RR Ferreira, MC Waghabi, ... British Journal of Clinical Pharmacology 86 (1), 143-154, 2020 | 23 | 2020 |
| Correlation of 6‐min walk test with left ventricular function and quality of life in heart failure due to Chagas disease MC Chambela, MFF Mediano, RR Ferreira, AM Japiassú, MC Waghabi, ... Tropical Medicine & International Health 22 (10), 1314-1321, 2017 | 22 | 2017 |
| Cellular Growth and Mitochondrial Ultrastructure of Leishmania (Viannia) braziliensis Promastigotes Are Affected by the Iron Chelator 2,2-Dipyridyl C Mesquita-Rodrigues, RFS Menna-Barreto, L Sabóia-Vahia, ... PLoS Neglected Tropical Diseases 7 (10), e2481, 2013 | 18 | 2013 |
